SEMA3A and ischemia: In particular, the lower doses, which we found here to allow the fastest stabilization, are not effective to restore blood flow in ischemia, whereas functional improvement requires higher doses, which induce similarly normal vessels, but of larger size, and promote effective collateral arteriogenesis (von Degenfeld et al, 2006), but also inhibit Sema3A expression and delay stabilization.